Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.47 |
| ▸ | TPSAB1 | Q15661 | 3/20 | 0.47 |
| ▸ | F2 | P00734 | 2/20 | 0.47 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.44 |
| ▸ | NSD2 | O96028 | 1/20 | 0.44 |
| ▸ | NSD3 | Q9BZ95 | 1/20 | 0.44 |
| ▸ | PLG | P00747 | 2/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.43 |
| ▸ | LY6K | Q17RY6 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL18334640 | 0.95 | PKM (0.45) | PKMPRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL18876552 | 0.92 | PKM (0.49) | PKMPRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL23836697 | 0.92 | PKM (0.50) | PKMPRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL17039654 | 0.92 | PKM (0.50) | PKMPRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL22994326 | 0.92 | PKM (0.50) | PKMPRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL25923982 | 0.92 | PKM (0.50) | PKMPRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL17039659 | 0.89 | FOLH1 (0.46) | PKMPRSS1PRSS2PRSS3TPSAB1 | |
| Trifluoroacetic Acid SCHEMBL22828936 | 0.89 | PKM (0.46) | PKMPRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL22840822 | 0.88 | L3MBTL3 (0.45) | PKMPRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL17039703 | 0.88 | L3MBTL3 (0.45) | PKMPRSS1PRSS2PRSS3TPSAB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11286285-B2 | Modified biotin, streptavidin mutant, and usage of them | SAVID THERAPEUTICS INC. (JP) | 2022-03-29 | — | — | US | disclosed |
| US-11161884-B2 | Modified biotin, streptavidin mutant, and usage of them | SAVID THERAPEUTICS INC. (JP) | 2021-11-02 | — | — | US | disclosed |
| US-11124549-B2 | — | — | 2021-09-21 | — | — | US | disclosed |
| EP-3842440-A2 | MODIFIED BIOTIN, STREPTAVIDIN MUTANT, AND USAGE OF THEM | Savid Therapeutics Inc. (JP) | 2021-06-30 | — | — | EP | disclosed |
| EP-3109252-B1 | MODIFIED BIOTIN, STREPTAVIDIN MUTANT, AND USAGE OF THEM | SAVID THERAPEUTICS INC (JP) | 2020-12-30 | — | — | EP | disclosed |
| US-20190382435-A1 | CLEARING AGENT | SAVID THERAPEUTICS INC. (JP) | 2019-12-19 | — | — | US | disclosed |
| US-20170145063-A1 | MODIFIED BIOTIN, STREPTAVIDIN MUTANT, AND USAGE OF THEM | SAVID THERAPEUTICS INC. (JP) | 2017-05-25 | — | — | US | disclosed |
| WO-2015125820-A1 | BIOTIN VARIANT, STREPTAVIDIN MUTANT, AND USES THEREOF | サヴィッド・セラピューティックス株式会社 | 2015-08-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170145063-A1 | MODIFIED BIOTIN, STREPTAVIDIN MUTANT, AND USAGE OF THEM | BTD, HLCS, BROX | PKM 4647/4885PRSS1 1862/4885PRSS2 1718/4885 |
| US-11124549-B2 | — | BTD, HLCS, BROX | PKM 4769/4885PRSS1 1346/4885PRSS2 1481/4885 |
| US-11161884-B2 | Modified biotin, streptavidin mutant, and usage of them | BTD, HLCS, BROX | PKM 4765/4885PRSS1 1074/4885PRSS2 1145/4885 |
| US-20190382435-A1 | CLEARING AGENT | MAN2B1, MAN2B2, ESYT1 | PKM 4490/4885PRSS1 894/4885PRSS2 851/4885 |
| US-11286285-B2 | Modified biotin, streptavidin mutant, and usage of them | BTD, HLCS, BROX | PKM 4647/4885PRSS1 1862/4885PRSS2 1718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.